Birdwell, Christine
Fiskus, Warren http://orcid.org/0000-0002-7343-6214
Kadia, Tapan M. http://orcid.org/0000-0002-9892-9832
DiNardo, Courtney D.
Mill, Christopher P.
Bhalla, Kapil N. http://orcid.org/0000-0001-5209-5126
Article History
Received: 7 January 2021
Revised: 25 February 2021
Accepted: 3 March 2021
First Online: 22 March 2021
Conflict of interest
: T.M.K. receives research funding from BMS/Celgene, Amgen, AstraZaneca, Astellas, Pfizer, AbbVie, Genentech, JAZZ, Cellenkos, InCyte, and Ascentage; T.M.K. serves as a consultant/advisory board member for Agios, Pfizer, Abbvie, Genentech, JAZZ, Daiichi Sankyo and Novartis. C.D.D. receives research funding from Abbvie, Agios, Calithera, Cleave, BMS/Celgene, Daiichi-Sankyo, ImmuneOnc and Loxo. C.D.D. serves as a consultant to Abbvie, Agios, Celgene/BMS, Daiichi Sankyo, ImmuneOnc, Novartis, and Takeda. C.D.D. serves on an advisory board with stock options for Notable Labs. K.N.B. serves as a consultant to Iterion Therapeutics. All other authors have no conflict of interest to declare.